Rapt Therapeutics Inc share price logo

Rapt Therapeutics Inc Share Price

NASDAQ: RAPT

$57.99

+0.02

(+0.03%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 2 Mar 2026

Rapt Therapeutics Inc Stock Performance

as on March 3, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $57.98
    $58.01
    downward going graph

    0.02%

    Downside

    0.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.67
    $58.02
    downward going graph

    90.23%

    Downside

    0.05%

    Upside

    downward going graph

Rapt Therapeutics Inc share price movements today

Previous Close
$57.98
Open
$58.00
Volume
12.4M
Day's Low - High
$57.98 - $58.01
52 Week Low - High
$5.67 - $58.02

Rapt Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Rapt Therapeutics Inc Stock Fundamentals & Key Indicators

Check Rapt Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Rapt Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rapt Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%
BUY$113.6B105.93%29.1632.94%
BUY$43.6B124.84%141.098.45%
NA$35.4BNA124.875.37%
BUY$82.2B60.41%18.7231.41%

Analyst Recommendation on Rapt Therapeutics Inc Stock

Based on 17 analysts

BUY

64.71%

Buy

35.29%

Hold

0.00%

Sell

Based on 17 analysts, 64.71% of analysts recommend a 'BUY' rating for Rapt Therapeutics Inc. Average target price of $58

Rapt Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Rapt Therapeutics Inc.

What analysts predicted

0.02%UPSIDE

Target Price

$58

Current Price

$57.99

Analyzed by

17 Analysts

Target

$58.00

Rapt Therapeutics Inc target price $58, a slight upside of 0.02% compared to current price of $57.99. According to 17 analysts rating.

Rapt Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
5
-
-
-
-
-
-
-
Gross Profit
0
0
4
0
0
-
-
-
0
-
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-25
-31
-30
-30
-27
-18
-53
-17
-17
-17
Net Profit Margin
0.00%
0.00%
-583.89%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Rapt Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
0
5
3
1
-
-
Gross Profit
-1
-1
-1
5
3
1
-3
-3
Operating Income
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-29
-36
-42
-52
-68
-81
-116
-129
Net Profit Margin
0.00%
0.00%
-4598.61%
-1049.03%
-1788.83%
-5362.21%
0.00%
0.00%

Global Institutional Holdings in Rapt Therapeutics Inc

Funds
Holdings
FCPM III SERVICES BV
1.19%
Perceptive Advisors LLC
1.11%
RTW INVESTMENTS, LLC
5.65%
Siren, L.L.C.
4.75%
Euclidean Capital LLC
0.5%

Rapt Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 20 January

    Tue, 04:24 PM

    -

    GSK agrees to acquire RAPT Therapeutics for $58 per share, valuing the company at $2.2 billion.

Insights on Rapt Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RAPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, RAPT stock has moved up by 348.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 57.3% return, outperforming this stock by 133.8%

About Rapt Therapeutics Inc

RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapies for patients living with inflammatory and immunological diseases. Its lead drug candidate, RPT904, is a half-life extended monoclonal antibody (mAb) designed to bind free human immunoglobin E (IgE), which is being developing for the treatment of food allergy, chronic spontaneous urticaria (CSU) and potentially other inflammatory diseases. The Company’s oncology drug candidate, tivumecirnon, is an oral small-molecule C-C motif chemokine receptor 4 (CCR4) antagonist designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors.
OrganisationRapt Therapeutics Inc
E-voting on sharesClick here to vote

FAQs

What is Rapt Therapeutics Inc share price today?

Rapt Therapeutics Inc share price today is $57.99 as on at the close of the market. Rapt Therapeutics Inc share today touched a day high of $58.01 and a low of $57.98.

What is the 52 week high and 52 week low for Rapt Therapeutics Inc share?

Rapt Therapeutics Inc share touched a 52 week high of $58.02 on and a 52 week low of $5.67 on . Rapt Therapeutics Inc stock price today i.e. is closed at $57.99,which is 0.05% down from its 52 week high and 923.62% up from its 52 week low.

How to invest in Rapt Therapeutics Inc Stock (RAPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rapt Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rapt Therapeutics Inc Shares that will get you 0.0259 shares as per Rapt Therapeutics Inc share price of $57.99 per share as on March 3, 2026 at 2:29 am IST.

What is the minimum amount required to buy Rapt Therapeutics Inc Stock (RAPT) from India?

Indian investors can start investing in Rapt Therapeutics Inc (RAPT) shares with as little as ₹92.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.80 in Rapt Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Rapt Therapeutics Inc share’s latest price of $57.99 as on March 3, 2026 at 2:29 am IST, you will get 0.1724 shares of Rapt Therapeutics Inc. Learn more about fractional shares .